On September 17, 2026, five insiders at Travere Therapeutics, Inc. (TVTX) executed sales of company stock, totaling approximately $29.95 million. Among the sellers were Chief Executive Officer Eric M. Dube, who sold shares across multiple transactions, and Evp, Chief Commercial Officer Peter Heerma.
Mr. Dube's sales amounted to roughly $19.00 million, while Mr. Heerma sold shares valued at approximately $10.96 million. These transactions occurred at prices ranging from $63.25 to $64.59 per share.
While insider selling can be attributed to various personal financial activities such as diversification or tax planning, a coordinated sale by multiple executives may attract investor attention.